feed,title,long_url,short_url
Benzinga,"Pfizer's RSV Candidate Shines with 82% Efficacy, Despite Competition in Crowded Field",https://benzinga.com/general/biotech/23/04/31697198/pfizers-rsv-candidate-shines-with-82-efficacy-despite-competition-in-crowded-field,https://da.gd/yczsM5
